BE890718A - Derives de cephalexine solubles dans l'eau, et procede pour leur preparation. - Google Patents

Derives de cephalexine solubles dans l'eau, et procede pour leur preparation.

Info

Publication number
BE890718A
BE890718A BE0/206233A BE206233A BE890718A BE 890718 A BE890718 A BE 890718A BE 0/206233 A BE0/206233 A BE 0/206233A BE 206233 A BE206233 A BE 206233A BE 890718 A BE890718 A BE 890718A
Authority
BE
Belgium
Prior art keywords
soluble
preparation
water
cephalexin
derivatives
Prior art date
Application number
BE0/206233A
Other languages
English (en)
Original Assignee
Neopharmed Spa
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmed Spa, Crinos Industria Farmaco filed Critical Neopharmed Spa
Publication of BE890718A publication Critical patent/BE890718A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE0/206233A 1980-10-13 1981-10-13 Derives de cephalexine solubles dans l'eau, et procede pour leur preparation. BE890718A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25267/80A IT1195762B (it) 1980-10-13 1980-10-13 Derivati idrosolubili della cefalexina e procedimento per la loro produzione

Publications (1)

Publication Number Publication Date
BE890718A true BE890718A (fr) 1982-02-01

Family

ID=11216176

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206233A BE890718A (fr) 1980-10-13 1981-10-13 Derives de cephalexine solubles dans l'eau, et procede pour leur preparation.

Country Status (17)

Country Link
US (1) US4471115A (fr)
EP (1) EP0049928B1 (fr)
JP (1) JPS5767583A (fr)
KR (1) KR880000691B1 (fr)
AR (1) AR229035A1 (fr)
AT (1) ATE35813T1 (fr)
AU (1) AU548333B2 (fr)
BE (1) BE890718A (fr)
CA (1) CA1181741A (fr)
DE (1) DE3176811D1 (fr)
DK (1) DK451281A (fr)
ES (1) ES506213A0 (fr)
FR (1) FR2491927B1 (fr)
IT (1) IT1195762B (fr)
NO (1) NO813433L (fr)
PT (1) PT73807B (fr)
YU (1) YU246381A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3759070A4 (fr) * 2018-02-28 2021-12-08 Bridge Biotherapeutics, Inc. Sels hydrosolubles de peptides lipidés et leurs procédés de préparation et d'utilisation
KR20200138326A (ko) * 2018-03-29 2020-12-09 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 염증성 시토카인을 억제하기 위한 약제학적 조성물
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1265315A (fr) * 1968-04-05 1972-03-01 Glaxo Lab Ltd
BE786924A (fr) * 1971-07-28 1973-01-29 Squibb & Sons Inc Antibiotiques, leur preparation et leurs utilisations therapeutiques
US3796709A (en) * 1971-11-19 1974-03-12 Squibb & Sons Inc (alpha-cyanamino)acetamidocephalosporins
BE792229A (fr) * 1971-12-03 1973-06-01 Bristol Myers Co Agents antibacteriens heterocycliques azotes et procede pour les preparer
US3880842A (en) * 1972-05-30 1975-04-29 Squibb & Sons Inc Cephalosporin derivatives
US3988326A (en) * 1974-02-22 1976-10-26 Meiji Seika Kaisha, Ltd. Process for N-acylation of 7 amino cephem compounds

Also Published As

Publication number Publication date
PT73807A (fr) 1981-11-01
CA1181741A (fr) 1985-01-29
YU246381A (en) 1983-10-31
FR2491927B1 (fr) 1985-07-12
IT1195762B (it) 1988-10-27
NO813433L (no) 1982-04-14
ATE35813T1 (de) 1988-08-15
IT8025267A0 (it) 1980-10-13
AU7624781A (en) 1982-04-22
EP0049928B1 (fr) 1988-07-20
KR830007681A (ko) 1983-11-04
DK451281A (da) 1982-04-14
PT73807B (fr) 1983-01-17
AU548333B2 (en) 1985-12-05
EP0049928A3 (en) 1983-04-06
KR880000691B1 (ko) 1988-04-23
AR229035A1 (es) 1983-05-31
FR2491927A1 (fr) 1982-04-16
JPS5767583A (en) 1982-04-24
ES8206533A1 (es) 1982-08-16
ES506213A0 (es) 1982-08-16
EP0049928A2 (fr) 1982-04-21
DE3176811D1 (en) 1988-08-25
US4471115A (en) 1984-09-11

Similar Documents

Publication Publication Date Title
FR2507183B1 (fr) Procede de preparation d'acides 6,8-difluoro-1,4-dihydro-4-oxo-quinoleine-3-carboxyliques
BE892395A (fr) Nouveaux derives de 3,4-dihydro-5h-2,3-benzidazepine et procede pour les preparer
MC1389A1 (fr) Derives d'imidazole et procede pour leur preparation
FR2515645B1 (fr) Derives de la proline optiquement actifs, procede pour leur preparation et leur application
FR2692586B1 (fr) Granules, procede pour les preparer et leur utilisation.
FR2509300B1 (fr) Derives d'azetidinone et procede pour leur preparation
BE875183A (fr) Procede pour la preparation de 2,2,6,6-tetramethyl-4-piperidone.
BE890331A (fr) Maleate de 2-amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)pyridine, procede pour sa preparation et son application comme medicament
MA21348A1 (fr) Procede pour la preparation de nouveaux derives aminoalcoxyphenyle.
MA19294A1 (fr) Procede de preparation d'imino-diacides substitues.
MA19188A1 (fr) Procede pour la production d'acetaldehyde de l'ethanol .
MA20154A1 (fr) Derives de 3-phenyl-4 cyanopyrole,procede pour leur preparation et elur application comme microbicides
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
RO84911A (fr) Procede pour la preparation des 1,1-alcandioles carboxyles
BE890718A (fr) Derives de cephalexine solubles dans l'eau, et procede pour leur preparation.
FR2576900B1 (fr) Derives de cyclohepto-imidazole 2-substitue, agents anti-ulcereux et procede pour leur preparation
FR2599037B1 (fr) Dihydrogeno-1,3 disilazanes fonctionnels et procede pour leur preparation
BE889339A (fr) 6-hydrazono-pyrido(2,1-b)quinazoline-11-ones et procede pour leur preparation
FR2533917B1 (fr) Derives 15-cycloaliphatiques de 13,14-bisdeshydro-carboprostacyclines et procede pour leur preparation
FR2503711B1 (fr) Derives de cepheme et procede pour leur preparation
BE888350A (fr) Procede pour la preparation de copolymeres thermoelastomeres-tri-sequences,
RO77754A (fr) Procede pour la preparation de la 1-phenyle-3-(1,2,3-thiadiazole-5-ile)-uree
FR2519638B1 (fr) Derives d'aminopropylaminobleomycine, leurs applications therapeutiques et procede pour leur preparation
FR2521556B1 (fr) Procede de preparation de 3, 3'-diamino-diphenylsulfones
FR2653765B1 (fr) Procede pour la preparation enantioselective de 2-aminotetralines.

Legal Events

Date Code Title Description
CH Change of patent owner

Owner name: *MIBA S.P.A.

Effective date: 19840224

RE Patent lapsed

Owner name: MIBA S.P.A.

Effective date: 19881031